Canadian medical cannabis company Canopy Growth has paid €225.9m in cash for C3, a German producer of pharmaceutical grade cannabinoids
Written by Freddie Dawson || 6th May 2019 || News analysis | Companies | Canada Europe Germany North America
Submit your access request to explore how it can streamlines access to critical cannabis insights
"*" indicates required fields
Notifications